chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I couldn't get out of bed for 10 hours the day after; super body aches; my head was so lightheaded; I couldn't focus on anything; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  An adult male patient received bnt162b2 (BNT162B2), intramuscular (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, Batch/lot number: Unknown), for COVID-19 immunization. The following information was reported: LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious), outcome "recovered", described as "I couldn't get out of bed for 10 hours the day after"; PAIN (non-serious), outcome "recovered", described as "super body aches"; DIZZINESS (non-serious), outcome "recovered", described as "my head was so lightheaded"; DISTURBANCE IN ATTENTION (non-serious), outcome "recovered", described as "I couldn't focus on anything". Therapeutic measures were not taken as a result of loss of personal independence in daily activities, pain, dizziness, disturbance in attention.  Additional information: Pfizer did not give the permission to contact the reporter about this event. The reason for batch number is unknown reported as not available to reporter at the time of report completion and unknown if facility where the most recent COVID-19 vaccine was administered. The patient receive any other vaccines within 4 weeks prior to the COVID vaccine was unknown and any other medications received within 2 weeks of vaccination was unknown, prior to vaccination the patient diagnosed with COVID-19 and since the vaccination the patient has been tested for COVID-19 was unknown. The reporter stated that he became aware of the information about fifteen minutes before the patient reported it on April 29, 2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
fever, chills, sore neck and sore arm. fatigue, duration: 4 hours.
Little tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Little tired) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 01SM20A or 015M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced FATIGUE (Little tired). On 11-Feb-2021, FATIGUE (Little tired) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Mar-2021, Hepatitis C: false positive (abnormal) False positive result.         Patient reported that before donating blood, he received a false positive Hepatitis C result. Concomitant medication was not provided Treatment information was not provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable   This case was linked to US-MODERNATX, INC.-MOD-2021-059819 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Follow up document was received on 26-MAY-2021. Reporter's address was added. Patient's first dose date, second dose batch no. were included. It contains significant information.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-059819:Wife case
Rash developed around injection site approximately one week after injection.  Rash was non-itchy, but took Zyrtec and applied ice as a precautionary measure.  Rash has largely subsided two days later.
Pt rcvd vax 10/9/99, on 10/12/99 L/upper arm had 3: x 4: erythematoma, inudration.  Pt had temp of 102.
Systemic: Dizziness / Lightheadness-Medium, Additional Details: called 911, emt came, per emt seemed okay and offered to bring to hospital, pt and family refused, rested for a bit more and left the pharmacy
aftereffects lingered for over 2 weeks and I am still somewhat compromised; headaches; weak legs- arms and shoulders more dominant on left side.; weak legs- arms and shoulders more dominant on left side.; This is a spontaneous report received from a contactable consumer (patient).   A 78-years-old female patient received bnt162b2 (BNT162B2), dose 2 intramuscular, administered in Arm Left on 17Feb2021 14:15 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation.Age at vaccination:78 years.Medical history included guillain-barre syndrome from Oct1986 and ongoing. The patient's concomitant medications were:None.The patient received first dose dose of the same vaccine 27Jan2021 at 01:45 P.M on left Arm via IM and developed headache and very weak legs on 27Jan2021 at  1:45 P.M. Vaccination Facility Type where the vaccine was administered was reported: Nursing Home/ Senior Living Facility. No other vaccines were received in the previous 4 weeks. The patient reported : Both shots resulted in days of headaches and very weak legs- arms and shoulders more dominant on left side. Second shot's aftereffects lingered for over 2 weeks and I am still somewhat compromised although, much, much improved. Onset date /time of the events was reported:17Feb 02:15. The patient underwent lab tests and procedures which included sars-cov-2 test: negative   on 2020 (Between summer and winter of 2020). Outcome of the events was recovering; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021245697 Same reporter,patient/different dose
Currently 17 weeks pregnant. Horrible headache, dizeness, vomiting, body aches, extreme fatigue
Redness all over arm a day after shot was administered. Site is itchy and slightly painful. Pt is taking clobetasol cream, MEDROL pack and CIPRO.
Initial report received from a health care professional on 18 Dec 2009: This patient was vaccinated with FLUVIRIN 0.5 ml, intramuscular, on 17 Dec 2009. On 17 Dec 2009, fifteen minutes after she received the vaccination, she experienced face swelling and pain with itching in her head. She went to emergency room and was treated and released. The outcome of the event was reported as resolved in less than 24 hours.
adult dose to a 19 month old patient; adult dose to a 19 month old patient; This case was reported by a other health professional via call center representative and described the occurrence of overdose in a 19-month-old female patient who received HAV (Havrix adult) (batch number g99r4, expiry date 20th May 2022) for prophylaxis.   Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 4th January 2022, the patient received Havrix adult and Havrix Pre-Filled Syringe Device. On 4th January 2022, unknown after receiving Havrix adult and Havrix Pre-Filled Syringe Device, the patient experienced overdose and adult product administered to child. On an unknown date, the outcome of the overdose and adult product administered to child were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The reporter reported that the administration of an adult dose of Havrix to an 19 month old patient, which led to overdose and adult product administered to child. No further events were reported. The reporter agreed to be contacted for follow-up.
This spontaneous report has been received from a pharmacist via a field employee concerning 1-2 patients of unknown age and gender. The patients' concomitant medication, pertinent medical history and drug reactions/allergies were not reported. On unknown dates, the patients were vaccinated with doses of ZOSTAVAX (lot # and expiration date not reported) subcutaneously. On unknown dates, after being administered ZOSTAVAX, the patients developed shingles. It was not specified how long after receiving the ZOSTAVAX the patients  developed shingles. The outcome of the event was unknown. The causal relationship between the event and ZOSTAVAX was not provided. Additional information is not expected, as there is no consent to contact the pharmacist.
Complain of itching all over 20 minutes after measles, mumps and rubella, BENADRYL 50mg by mouth given 11:00am.  Improvement in itching 20 minutes later.
None- vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 041L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was provided by the reporter. No treatment medications was provided by the reporter.   This case was linked to (Patient Link).
Site: Pain at Injection Site-Medium, Systemic: Numbness (specify: facial area, extremities)-Severe, Systemic: Unable to Sleep-Medium, Additional Details: Patient reports experiencing numbness in both arms, has doctor's appt scheduled for further follow-up
No additional AEs were reported; a patient received improperly stored vaccine on 4/20/2023; This spontaneous report was received from a pharmacist and referred to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 20-APR-2023, the patient was vaccinated with the first dose of improperly stored vaccine (temperature: 35.1F; time frame: 16 hours 45 minutes) of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid orally for prophylaxis (lot #W014173, expiration date: 15-NOV-2023, strength and dose were not provided) (product storage error). No additional AEs were reported (no adverse event). There was no previous temperature excursion.
Date of Admission: 10/19/2022 Date of Discharge: 10/26/2022   Active Hospital Problems   Diagnosis o Heart failure (CMS/HCC) o Stress-induced cardiomyopathy o COVID-19 o Myocarditis (CMS/HCC) o HLD o Coronary artery disease involving native coronary artery of native heart without angina pectoris o HTN
States arm sore after vaccine so "took break from gym for 2 wks".  In Oct. '21 went back to lifting  in gym.  Nov. '21 saw provider at Health Center.  X-rays taken.  No problems identified.  Shoulder continues with soreness when given vaccine and occasionally it goes down the arm to fingers.   Given medication without improvement.  Was recommended to see Physical Therapist but didn't as thought he was going to gym and that was exercise.  Planning to see Physical Therapist.
Initially after getting the shot I had no major symptoms. After a while I started getting dizzy and went to see my PCP who asked for a full CBC blood work. Found out that my platelets count was low so the investigation started to find out why and after seeing several doctors (PCP, GI, Surgeon, Hematologist, Hepatologist) and doing several tests and imaging, the results showed that I have a cavernous transformation of the portal vein (Something that I never had before). The issues continued with my liver and spleen being enlarged causing pressure in the veins in my stomach and oesophagus which eventually busted causing me to have internal bleeding. An emergency endoscopy was performed and banding of the oesophageal varices was performed. Additionally,  a blood clot was found in my portal vein that is causing more stress to the functions of the liver and surrounding organs. All my blood counts are very low and I had to get blood transfusions and Iron transfusions. The treatment is ongoing to figure out what needs to happen with the clots and if blood thinners are a good option since I'm constantly bleeding from tiny veins.
Elevated temperature to 103.4 axillary, redness and swelling left leg. Elevated temperature for over 48 hours.
I have tested positive (and am showing symptoms of) COVID-19 four months after receiving my vaccine. I am on day 8 of showing symptoms.
Severe pain and swelling, redness, possible cellulitis. Had to go to ER in the evening. Now finishing anti-biotics.
Initial misuse report received from a healthcare professional on 19 February 2013. A 12-year-old patient was administered MENACTRA, ADACEL and VARIVAX vaccines mixed in one syringe and as a single injection in the deltoid. The reporter was not sure if the VARIVAX diluent was added to the mixture. No adverse event was reported. List of documents held by sender: none.
patient received meningococcal and pneumococcal vaccines in left UE on 6/12/08 in preparation for travel.  Developed redness and pain at site that rapidly progressed requiring hospital admission.  MRI obtained related to pain out of proportion to exam and could not r/o fasciitis.  Admitted to surgery service on Vancomycin and Zosyn and monitoring for evidence of nec. fasc.  6/24/08 MR received from PCP 6/13/2008 and hospital DOS 6/16-18/2008 with DX: Left Upper Arm Cellulitis. Seen 6/13/08 for sinusitis and vaccinations for travel. Pt presented to ER with 3 day hx of rapidly spreading redness, swelling and pain at left arm injection site. Fever up to 102'F with malaise. Pt also reports onset today of pain in chest which increases with breathing.  PE (+) for painful distress, L upper arm erythema and firmness. ID consult with assessment vaccination reaction  vs soft tissue infection with concern for myositis.
patient had  a hot feeling all over her body and her skin was red. . had no rash, no fever, no lesions. this resolved on its own.
Patient awoke the next morning, 5/22/2019, and could not stand up.  Her legs were profoundly weak, had a difficult time standing up, ambulated very little.  Was not able to get out of the house for at least 3 days following the vaccine.  Numbness was present in her thighs along with the weakness.  The numbness has slowly progressed down the legs and as of today is located around her ankles and feet.  This sensation has left her upper legs as it migrated down the lower extremity.  However, she is still having a very difficult time walking, legs are still profoundly weak and tired.  Difficulty ambulating without holding onto furniture, chairs, etc.  Has never needed any assistive device in walking prior to this.
massive joint pain; severe pain in both calves; severe sickness mimicing the flu for >1 week; severe sickness mimicing the flu for >1 week; flare of arthritis; other vaccine same date product=Prevnar; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 27Jan2022 (Lot number: FL3209) at the age of 49 years as dose 3 (booster), single for covid-19 immunisation; pneumococcal vaccine conj 7v (crm197) (PREVNAR), administered in arm left, administration date 27Jan2022 (Batch/Lot number: unknown) as dose 1, single for immunisation. Relevant medical history included: "Spondoloarthritis" (unspecified if ongoing); "Heart Disease" (unspecified if ongoing); "known allergies DAIRY" (unspecified if ongoing). Concomitant medication(s) included: PLAVIX; REPATHA; ASPIRIN [ACETYLSALICYLIC ACID]; HUMIRA; VIBERZI; SINGULAIR. Vaccination history included: Bnt162b2 (DOSE 2, SINGLE., Batch/Lot No: EN6199, Location of injection: Arm Left), administration date: 27Mar2021, when the patient was 48 years old, for COVID-19 Immunization, reaction(s): "administration date: 27Mar2021, prev dose dose number: 2; prev dose administration date: 27Jan2021, prev dose dose number: 1"; Bnt162b2 (DOSE 1, SINGLE., Batch/Lot No: EN6201, Location of injection: Arm Left), administration date: 27Jan2021, when the patient was 48 years old, for COVID-19 Immunization. The following information was reported: ARTHRALGIA (non-serious) with onset 28Jan2022, outcome "not recovered", described as "massive joint pain"; PAIN IN EXTREMITY (non-serious) with onset 28Jan2022, outcome "not recovered", described as "severe pain in both calves"; ILLNESS (non-serious), INFLUENZA LIKE ILLNESS (non-serious) all with onset 28Jan2022, outcome "not recovered" and all described as "severe sickness mimicing the flu for >1 week"; ARTHRITIS (non-serious) with onset 28Jan2022, outcome "not recovered", described as "flare of arthritis"; PRODUCT USE ISSUE (non-serious) with onset 27Jan2022, outcome "unknown", described as "other vaccine same date product=Prevnar". The events "massive joint pain", "severe pain in both calves", "severe sickness mimicing the flu for >1 week", "severe sickness mimicing the flu for >1 week" and "flare of arthritis" were evaluated at the physician office visit. It was unknown if therapeutic measures were taken as a result of arthralgia, pain in extremity, illness, influenza like illness, arthritis. Additional information:Reported events included trying to get into a Dr. for evaluation massive joint pain, forearm pain, severe pain in both calves, severe sickness mimicking the flu for >1 week; flare of arthritis. Events resulted in doctor or other healthcare professional office/clinic visit. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Device date was reported as 07Feb2022.  No follow-up attempts are possible. No further information is expected.
102 degree fever, severe chills, severe muscle / body aches, severe headache exacerbation, severe diarrhea for 36 hours and hypovolemia, severe exacerbation in chronic abdominal pain, severe exacerbation in chronic joint pain, severe fatigue, insomnia, exacerbation in nausea and food intolerance
Received vaccination at 3;30 pm and by 8 pm had intense pain in left knee.  15 minutes later left knee would not bear my weight and was forced to use crutches.  Saw MD next day and received a shot in knee.  By that evening my left hand had swollen up and was painful enough that i could not use it.  Had MRI on left knee on May13th which showed no problems with knee whatsoever.  Received shot for swelling in hand and as of this writing it is still somewhat swollen but am able to use it with little to no pain.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 30-MAR-2016, the patient was vaccinated with an improperly stored dose of GARDASIL 0.5 ml (lot # K011492, expiration date 22-JUN-2016). No adverse effects were reported. This specified lot number vaccine was exposed to temperature excursion three times. The total cumulative excursion time (hour), the lowest recorded temperature (Fahrenheit degree/Celsius) and the type of excursion (R/F) for each time were 24, 34 and R. The total cumulative excursion time (hour), the highest recorded temperature (Fahrenheit degree/Celsius) and the type of excursion (R/F) for each time were 176, 48 and R; 48, 47 and R. The storage criteria was refrigerator (R). This is one of several reports received from the same source. Additional information has been requested.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  CHRONIC HYPOXEMIC RESPIRATORY FAILURE
After 2nd shot the night of vaccination for 2 days git very sick nausea, vomiting, severe headache, fatigue, body ache , fever 101.3 Chills Did not go to any medical facility since I was expecting might happen only called nurse to stop my vomiting could not keep any liquid or food which she suggested try Gatorade drink which helped me with nausea . Got better in 3 days . What worries me the same happened yesterday almost after 2 weeks from vaccination since yesterday morning 04/28/21 all symptoms only no nausea and today also I am sick taking advil I gave a corona test yesterday which result was negative . Just wanted to inform the symptoms repeat again through some weeks the same happened to my sister who got moderna shot
3.5 in x 6.0 in area of redness, warmth and swelling
Information has been received from a physician concerning a "couple" patients who on an unspecified date were vaccinated with GARDASIL (therapy dose, route and site unknown). Subsequently the patients fainted after receiving vaccination. Subsequently, the patients recovered. The health care professional contacted during telephone follow-up could not supply the following information: patient name, date of birth, dates of vaccination, dose number, lot number, date of event, and hospital name (if applicable). Follow-up information has been received from the physician. The physician reported that one of the patients felt faint. The patient had loss of consciousness for few seconds. The patient had got 5 vaccines, not just GARDASIL. The physician could not recalled the patient's identities. This is one of several reports from the same source. No further information is available.
68y.o. female with PMH pertinent for seronegative RA on chronic prednisone recent COVID PNA presented for worsening SOB. In the ER, patient was hypoxic requiring HFNC 100% FiO2/50 L and a nonrebreather maintaining SPO2 in the early 90s.  Significant increase in work of breathing.  Patient was intubated. On 8/28, the patient developed resp distress. Patient had a needle decompression and then chest tube placement for right sided tension pneumothorax. Patient was unable to be weaned off ventilator and on 9/5 had a drop in SpO2 with increased WOB. Patient required multiple pressors for hemodynamic instability. Patient transitioned to comfort care, and passed peacefully that evening.
Red bumps resembling a topic dermatitis from left elbow to wrist that were itchy. Treated with triamcinolone cream. Appeared 4 days after vaccine.   Red blotchy rash on upper arm directly above vaccine site 11 days after injection.
1 1/2 hr p/taking first capsule had abdo cramping, pain & nausea;
I would not call this an adverse event but rather a reaction. Following the fever, chills and fatigue resulting in the need to take off work I developed an eye infection, conjunctivitis and cold sores inside my nose and on my upper lip.  The cold sores are diminishing and I could only obtain the medicated eye drops on 11/8 in the evening. I am monitoring the eye infection and still have moderate fatigue. I was 100% healthy prior to receiving the booster and had the J&J vaccine March 16, 2021.
urticaria starting around site and then spreading other areas on body. Improved with diphenhydramine, but returned the next afternoon and then again the next afternoon. Subsequently developed a fever (temp to 101).
Red rash half way around injection site; noticed rash at home 9-1-07.
ON WEDNESDAY JUNE 23, PT'S ROOF OF MOUTH STARTED FEELING NUMB. ON 06/24/21 BEHIND HER EAR STARTED HURTING.
Patient developed fever of 103F on 4/06/03, nausia myalgia & arthralgia & generalized vaccinia, red positive pusuleas, puritis.  seen in ER & admitted to hospital for observation and Benadryl, tylenol.  Patient received and released.